The Latest Breaking News from Jazz

Jazz stock toppled Thursday — but shares of key rival Praxis surged — after its essential tremor drug failed in midstage testing.

Jazz icon Herbie Hancock bought this Cobra with his first real paycheck. He still owns it today.

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the surging popularity of plant-based products. Hence, quality biotech stocks, Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Jazz Pharmaceuticals (JAZZ) could be ideal investments for solid returns. Read more….

We've seen some interest from the Los Angeles Lakers and Philadelphia 76ers, but what about the Jazz?

An otherwise competitive rivalry turned historically lopsided for one game.

The Jazz's new purple and white jerseys should have never gone away.

The biotech industry's prospects look promising due to the use of advanced technologies like AI and VR for research, the growing popularity of tailored treatments and biotech devices, a rise in chronic diseases, and increased R&D spending. Therefore, investors could consider buying biotech stocks Innoviva (INVA), Halozyme Therapeutics (HALO), Jazz…

Would the Suns actually target Bronny James in the first round?

Could Chicago Bulls forward Patrick Williams sign an offer sheet with the Utah Jazz in free agency?

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

Will the Jazz force the Lakers to trade up for Bronny?